Exciting news in the world of urban air mobility as Eve Air Mobility announces a significant funding round of $94,000,000. Specializing in electric vertical takeoff and landing vehicles (eVTOL), Eve is at the forefront of revolutionizing transportation solutions for urban settings. This latest injection of funds will support the continued development and certification of their eVTOL vehicle, as well as the expansion of their services and support network. Additionally, Eve will focus on creating innovative urban air traffic management solutions to ensure the safe and efficient integration of eVTOLs into urban airspace. With this substantial funding, Eve Air Mobility is poised to make significant strides towards creating a more sustainable and accessible future of transportation.
Sky's the Limit: Eve Air Mobility Secures $94 Million in Funding for Innovative UAM Solutions
Recently funded 路 $94.0MTransportation
Get the full Eve Air Mobility company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
